Skip to main content
Caplight Logo









Nostics

Nostics

Private
AmsterdamHealthcare & Life Scienceshttps://nostics.com/

Last Round

Seed

Oct 26, 2023

Total Funding Raised

$5.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nostics is a medical diagnostics company that develops a nanotechnology-based platform for rapid, accessible, and affordable infectious disease diagnostics by integrating Raman spectroscopy, nanotechnology, and AI-based classification.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

point-of-care testingPOCTpathogen identificationRaman spectroscopymedical diagnosticsantimicrobial stewardshiprapid diagnosticsAI diagnosticsclinical diagnostic toolsspectral analysisdiagnostic hardwarelab-on-a-chipnanotechnologydiagnostic cartridgesmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nostics Comparables

Compare Nostics with similar companies based on industry and business-model similarity.

Nostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivid Dx
86%
MagIC Lifescience
85%
Detechgene
83%

Nostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 26, 2023
SeedMay 12, 2020

Key People

Founding team and executive leadership

Eva Rennen

Co-Founder COO

Founding Team

Rochelle Niemeijer

Co-Founder Chief Scientific Officer

Founding Team

Jeroen Nieuwenhuis

Chief Executive Officer

Executive Team

Nostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 109% MoM, reaching 722.

  • Oct 9, 2025

    Developing rapid bacterial identification solutions with portable Raman spectrometers.

Nostics Filings

Explore SEC and related filing metadata, where available.

Nostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nostics's valuation, stock price, and market status.

Is Nostics a public or private company?

Nostics is a private company.

What is the current stock price of Nostics?

Nostics is a private company with no public stock price. No recent secondary market data is available.

How much is Nostics worth (valuation)?

Valuation information for Nostics is not publicly available.

Can I buy Nostics stock?

Nostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nostics's last funding round?

Nostics's most recent funding round was Seed on October 26, 2023.

Who are the main investors in Nostics?

Key investors in Nostics include Health Investment Partners.

Will Nostics IPO soon?

No public IPO plans have been announced for Nostics.

How can I track Nostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range28
Year Founded2020
Last FundingOct 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?